U.S. Ventricular Assist Devices Market

U.S. Ventricular Assist Devices Market Size, Share, Growth Analysis, By Product(Left Ventricular Assist Device, Right Ventricular Assist Device), By Type of Flow(Pulsatile Flow, Continuous Flow), By Application(Bridge to Transplant (BTT), Bridge to Candidacy (BTC)), By End-user(Hospitals & ASCs, Specialty Clinics & Others), By Region/Country(Northeast, Southeast) - Industry Forecast 2024-2031


Report ID: UCMIR35A2898 | Region: Regional | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

U.S. Ventricular Assist Devices Market Insights

Market Overview:

The market for ventricular assist devices (VADs) in the United States reached a value of USD 582.0 million in 2022 and is anticipated to experience a growth rate of 10.5% throughout the projected period. Heart failure, a disruption in the heart's normal operation, has become increasingly prevalent in the U.S., affecting approximately 6.2 million individuals in 2020 according to data from the Centers for Disease Control and Prevention (CDC). Additionally, the elderly demographic is particularly susceptible to cardiovascular conditions, making ventricular assist devices (VADs) crucial mechanical circulatory support (MCS) solutions for those with ailing hearts.

U.S. Ventricular Assist Devices Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Equipment by segment aggregation, the contribution of the Health Care Equipment in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for U.S. Ventricular Assist Devices was estimated to be valued at US$ XX Mn in 2021.

The U.S. Ventricular Assist Devices Market is estimated to grow at a CAGR of XX% by 2028.

The U.S. Ventricular Assist Devices Market is segmented on the basis of Product, Type of Flow, Application, End-user, Region/Country.

Based on region, the U.S. Ventricular Assist Devices Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the U.S. Ventricular Assist Devices Market are Berlin Heart, ABIOMED (Johnson & Johnson Services, Inc., Abbott , Jarvik Heart, Inc..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

U.S. Ventricular Assist Devices Market

Product ID: UCMIR35A2898

$5,300
BUY NOW GET FREE SAMPLE